Emergence of BA9 genotype of human respiratory syncytial virus subgroup B in China from 2006 to 2014
Jinhua Song(National Institute for Viral Disease Control and Prevention), Wenbo Xu(Shenyang Institute of Automation), Liwei Sun(Chinese Center For Disease Control and Prevention), Zifeng Yang(First Affiliated Hospital of Guangzhou Medical University), Paul B. Yu(University of Oxford), Rongbo Zhang(Anhui University of Science and Technology), Chaofeng Ma(Xian Center for Disease Control and Prevention), Teresa I. Ng(AbbVie (United States)), Huiling Wang(Wuhan University), Yan Zhang(Memorial Sloan Kettering Cancer Center), Jing Shi(Hubei University of Arts and Science), Qi Li(Hebei Provincial Center for Disease Control and Prevention), Ai‐Li Cui(Sichuan University), Xingyu Xiang(National Health and Family Planning Commission), Yanzhi Huang(Changchun Children's Hospital)
Cited by 40
Related Papers
A Novel Coronavirus from Patients with Pneumonia in China, 2019
|New England Journal of Medicine|2020|30.5k
Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
|The Lancet|2020|12.6k
The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice
|Nature|2020|1.2k
Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARS-CoV-2
|Cell|2020|802
Etiological and epidemiological features of acute respiratory infections in China
|Nature Communications|2021|530